© 2004 BMJ Publishing Group Ltd & Association of Clinical Pathologists
CASE REPORT
Atypical haemolytic uraemic syndrome as a complication of induction chemotherapy for acute lymphoblastic leukaemia
Birmingham Childrens Hospital, Steelhouse Lane, Birmingham B4 6NH, UK
Correspondence to:
Correspondence to:
Dr D Chandra
Department of Paediatric Haematology, Birmingham Childrens Hospital, Steelhouse Lane, Birmingham, B4 6NH, UK; deepak.chandra{at}bch.nhs.uk
This report describes a case of fatal haemolytic uraemic syndrome (HUS) developing in a child with acute lymphoblastic leukaemia (ALL) during induction chemotherapy. The aetiology in this case is uncertain but it may have resulted from treatment with L-asparaginase or vincristine. The possibility of HUS during induction chemotherapy for ALL should be considered early on in the treatment regimen, if clinical signs and symptoms suggest this diagnosis, so that appropriate treatment can be instituted.
Keywords: haemolytic uraemic syndrome; acute lymphoblastic leukaemia; TTP
Abbreviations: ALL, acute lymphoblastic leukaemia; CT, computed tomography; HUS, haemolytic uraemic syndrome; TTP, thrombotic thrombocytopenic purpura
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
